Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units

International Journal of Antimicrobial Agents

Volumn 27, Issue 4, 2006, Pages 285-289

  Wroblewska, Marta M ^a   Rudnicka, Jolanta ^a   Marchel, Halina ^a   Luczak, Miroslaw ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Gram negative bacilli; Intensive Care Units; Multidrug resistance

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; IMIPENEM;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOOD CULTURE; CONTROLLED STUDY; ENZYME SYNTHESIS; GRAM NEGATIVE AEROBIC RODS AND COCCI; HOSPITAL INFECTION; HOSPITALIZATION; INTENSIVE CARE UNIT; LENGTH OF STAY; MEDICAL RECORD; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; WARD;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IMIPENEM; INPATIENTS; INTENSIVE CARE UNITS; LENGTH OF STAY; MICROBIAL SENSITIVITY TESTS; RISK FACTORS;

EID: 33645994225     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.11.015     Document Type: Article

References (22)

1. Singh A.K., Sen M.R., Anupurba S., and Bhattacharya P. Antibiotic sensitivity pattern of the bacteria isolated from nosocomial infections in ICU. J Commun Dis 34 (2002) 257-263
2. Fridkin S.K. Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med 29 Suppl. 4 (2001) N64-N68
3. Wroblewska M.M., Marchel H., and Luczak M. Multidrug resistance in bacterial isolates from blood cultures of haematology patients. Int J Antimicrob Agents 19 (2002) 237-240
4. Namias N., Samiian L., Nino D., et al. Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: implications for empiric antibiotic strategies. J Trauma 49 (2000) 638-645 [discussion 645-6]
5. Hsueh P.R., Liu Y.C., Yang D., et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist 7 (2001) 373-382
6. Paterson D.L., and Rice L.B. Empirical antibiotic choice for the seriously ill patient: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive?. Clin Infect Dis 36 (2003) 1006-1012
7. Jarlier V., Nicolas M.H., Fournier G., and Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10 (1988) 867-878
8. Johnson AP, Henwood C, Mushtaq S, et al.; ICU Study Group. Susceptibility of Gram-positive bacteria from ICU patients in UK hospitals to antimicrobial agents. J Hosp Infect 2003;54:179-87.
9. Fridkin S.K., and Gaynes R.P. Antimicrobial resistance in intensive care units. Clin Chest Med 20 (1999) 303-316
10. Geffers C., Zuschneid I., Sohr D., Ruden H., and Gastmeier P. Microbiological isolates associated with nosocomial infections in intensive care units: data of 274 intensive care units participating in the German Nosocomial Infections Surveillance System (KISS). Anasthesiol Intensivmed Notfallmed Schmertzther 39 (2004) 15-19
11. Hanberger H., Garcia-Rodriguez J.A., Gobernado M., Goossens H., Nilsson L.E., and Struelens M.J. Antibiotic susceptibility among gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA 281 (1999) 67-71
12. Freidland I., Stinson L., Ikaiddi M., Harm S., and Woods G.L. Phenotypic antimicrobial resistance patterns in Pseudomonas aeruginosa and Acinetobacter: results of a Multicenter Intensive Care Unit Surveillance Study, 1995-2000. Diagn Microbiol Infect Dis 45 (2003) 245-250
13. Karlowsky J.A., Draghi D.C., Jones M.E., Thornsberry C., Friedland I.R., and Sahm D.F. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother 47 (2003) 1681-1688
14. Glupczynski Y, Delmee M, Goossens H, Struelens M; Belgian Multicenter ICU Study Group. Distribution and prevalence of antimicrobial resistance among gram-negative isolates in intensive care units (ICU) in Belgian hospitals between 1996 and 1999. Acta Clin Belg 2001;56:297-306.
15. Vidal F., Mensa J., Almela M., et al. Bacteraemia in adults due to glucose non-fermentative Gram-negative bacilli other than P. aeruginosa. QJM 96 (2003) 227-234
16. Podnos Y.D., Cinat M.E., Wilson S.E., Cooke J., Gornick W., and Thrupp L.D. Eradication of multi-drug resistant Acinetobacter from an intensive care unit. Surg Infect (Larchmt) 2 (2001) 297-301
17. Wroblewska M.M., Dijkshoorn L., Marchel H., et al. Outbreak of nosocomial meningitis caused by Acinetobacter baumannii in neurosurgical patients. J Hosp Infect 57 (2004) 300-307
18. Fierobe L., Lucet J.C., Decre D., et al. An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients. Infect Control Hosp Epidemiol 22 (2001) 35-40
19. Weist K., Pollege K., Schulz I., Ruden H., and Gastmeier P. How many nosocomial infections are associated with cross-transmission? A prospective cohort study in a surgical intensive care unit. Infect Control Hosp Epidemiol 23 (2002) 127-132
20. Luna C.M., Gherardi C., Famiglietti A., and Vay C. Bacterial resistance and antimicrobial therapy in respiratory medicine and intensive care. Medicina 61 (2001) 603-613
21. Shlaes D.M., Gerding D.N., John Jr. J.F., et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 18 (1997) 275-291
22. Raveh D., Rudensky B., Schlesinger Y., Benenson S., and Yinnon A.M. Susceptibility trends in bacteraemias: analyses of 7544 patient-unique bacteraemic episodes spanning 11 years (1990-2000). J Hosp Infect 55 (2003) 196-203